Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MCUJF:US

2.0000 USD 0.0760 3.95%

As of 20:10:00 ET on 05/19/2015.

Snapshot for Medicure Inc (MCUJF)

Open: 2.0000 Day's Range: 2.0000 - 2.0000 Volume: 2,100
Previous Close: 1.9240 52wk Range: 0.9550 - 2.7290 1-Yr Rtn: +36.99%

Stock Chart for MCUJF

No chart data available.
  • MCUJF:US 2.0000
  • 1D
  • 1M
  • 1Y
1.9240
Interactive MCUJF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MCUJF

Current P/E Ratio (ttm) -
Estimated P/E(05/2015) 61.5250
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (05/2015) 0.0400
Est. PEG Ratio -
Market Cap (M USD) 25.05
Shares Outstanding (M) 12.52
30 Day Average Volume 3,587
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MCUJF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for MCUJF

Medicure Inc. is a cardiovascular drug discovery and development company focused on developing therapeutics for unmet needs in the field of cardiovascular medicine. The Company's current focus is on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.

Albert D FriesenChairman/CEO/FounderDawson J ReimerPresident/COO
James F KinleyCFO/SecretaryEvan DriedgerInvestor Relations
More Company Profile & Key Executives for MCUJF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil